Co-Diagnostics, Inc. Announces Second Quarter 2023 Earnings Release Date and Webcast
- Futures edge up on Fed pivot hopes, jobs data in focus
- MongoDB delivers upbeat guidance after Q3 results beat
- Stocks, gold gain as investors stay cheery on rate outlook
- SentinelOne rallies 20% as Q3 results suggest momentum is accelerating
- PayPal (PYPL) stock falls as Bank of America downgrades on 'too high' 2024 estimates
The conference call and webcast will be available via:
Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a
*The Co-Dx PCR Home platform is subject to FDA review and is not currently for sale.
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-second-quarter-2023-earnings-release-date-and-webcast-301887167.html
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thinkific Announces Suite of New Features for Thinkific Plus to Further Fuel the Growth of its Enterprise Platform for Customer Education
- LEAVE A BOX AND GET A BOX: PIZZA HUT LAUNCHES "REVERSE DELIVERY" DOORMAT TO GIFT PIZZA TO DELIVERY DRIVERS THIS HOLIDAY SEASON
- Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway
Create E-mail Alert Related CategoriesPRNewswire, Press Releases
Related EntitiesEarnings, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!